MedPath

Investigation into the protective effects of apple juice on the intestinal barrier in athletes

Not Applicable
Recruiting
Conditions
no deseases are investigatedhealthy volunteers
Registration Number
DRKS00027860
Lead Sponsor
DSHS Köln, Kreislaufforschung und Sportmedizin, Abt.2
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
20
Inclusion Criteria

healthy endurance athletes with an age of 18-60 years

Exclusion Criteria

Hormone substitution; incl. thyroid Hormone therapy
Smokers
One-sided diet (e.g. vegan)
People in need of treatment
Cardiac arrhythmia Heart failure (EF<55)
Performance-limiting pAVK (Fontaine stage = II)
Performance- or training-limiting degenerative joint diseases or muscular diseases
Performance-limiting kidney disease
Performance-limiting neurological disease
oncological diseases in the history (< 5 years)
Psychiatric and/or addictive disorders

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
9ml venous blood sampling at the time points:<br>T0 (start of examination day), T1 (immediately after physical exercise), T2 (+40 min after beverage consumption), T3 (+80 min after beverage consumption), T4 (+120 min after beverage consumption), T5 (+180 min after beverage consumption), T6 (24h after beverage consumption).<br><br>The following parameters should be examined:<br>Intestinal fatty acid-binding proteins (I-FABP), zonulin, lipopolysaccharide binding protein (LBP), bacterial endotoxin, determination of toll-like receptors in isolated peripheral mononuclear cells (PBMC), interleukin 6 and 10 (IL 6, IL 10), macrophage migration inhibitory factor (MIF), oxidative stress; creatine kinase (CK) and myoglobin; lactate (measurement at T1).<br><br>
Secondary Outcome Measures
NameTimeMethod
Stool sampling (Art. No. (PZN): 4865079)<br><br>Microbiota examination by means of 16 S amplicon analysis
© Copyright 2025. All Rights Reserved by MedPath